Frontlight ResearchEarly access
Lung cancer trials in United States
900 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in United StatesA New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial
- Where
- Winston-Salem
- Age
- 18 years and over
- People
- 194
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT07282444 - Phase 3Taking peopleA Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
- Where
- Athens, Augusta, Beverly Hills, Bullhead City, Charleston, Cincinnati, Clermont, Columbia, Coral Springs, Daphne, Dyer, Fountain Valley, Galveston, Glendale, Green Bay, Hialeah, Houston, Lakewood, Lancaster, Laurelton, Los Alamitos, Los Angeles, Marietta, Marshfield, Monterey, New York, Oakland, Oklahoma City, Pittsburgh, Pleasant Hill, Richmond, San Antonio, Spokane, Tamarac, Urbana, Walnut Creek, Westbury, Winchester, Winston-Salem, York
- Age
- 18 years and over
- People
- 750 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07361510 · EU 2025-523586-18-00 - Phase 2Taking peopleA Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Where
- Athens, Baltimore, Columbus, Grand Island, Hattiesburg, Houston, Lexington, Madison, New York, Omaha, Washington D.C.
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07680764 · EU 2026-525170-19-00 - No phaseTaking peopleBRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor Malignancies
- Where
- Miami
- Age
- 18 years and over
- People
- 40
- Run by
- University of Miami
See details and how to joinNCT07789912 - Phase 1Taking peoplePhase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
- Where
- Boston, Fairfax, Irving, Lubbock, Oklahoma City, Orlando
- Age
- 18 years and over
- People
- 285
- Run by
- Sutro Biopharma, Inc.
See details and how to joinNCT07807345 - Phase 2Taking peopleA Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- Where
- Athens, Chandler, Charleston, Chicago, Dallas, East Brunswick, Fairfax, Greenville, Honolulu, Jacksonville, Lincoln, Little Rock, Los Angeles, Marietta, Nashville, New Haven, Niles, Ocala, Ogden, Omaha, Oxnard, Pembroke Pines, Peoria, Perrysburg, Pinehurst, Reno, Savannah, Sayre, Spokane, Springfield, St. Petersburg, Tacoma, Teaneck, The Bronx, Tyler, Westbury, West Palm Beach, York, Zanesville
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- AbbVie
See details and how to joinNCT06568939 - Phase 2Taking peopleA Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Where
- Baltimore, Birmingham, Chicago, Galveston, Goodyear, Houston, Irvine, Jacksonville, Knoxville, Munster, Nashville, Newark, Portland, Rochester, St Louis, Temple, Washington D.C.
- Age
- 18 years and over
- People
- 300
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07154290 - Phase 1/2Taking peopleA Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
- Where
- Celebration, Fairfax, Hackensack, Nashville, New Hyde Park
- Age
- 18 years and over
- People
- 428 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07287995 - Phase 1Taking peopleA Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- Where
- Houston, San Antonio, Scottsdale
- Age
- 18 years and over
- People
- 30
- Run by
- SHY Therapeutics
See details and how to joinNCT07705334 - No phaseTaking peopleLung Cancer Detection in Never Smokers Using Urine Volatile Organic Compound (VOCs)
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 87
- Run by
- Thomas Jefferson University
See details and how to joinNCT07871656 - Phase 2Taking peopleFeasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®
- Where
- New York
- Age
- 18 years and over
- People
- 40
- Run by
- CivaTech Oncology
See details and how to joinNCT03290534 - Phase 2Taking peopleStudy of PF-07248144 in Advanced or Metastatic Solid Tumors
- Where
- Conroe, Edgewood, Fort Lauderdale, Houston, League City, Los Angeles, Louisville, Nashville, New Haven, San Antonio, San Francisco, Scottsdale, Seattle, Sugar Land
- Age
- 18 years and over
- People
- 320 worldwide
- Run by
- Pfizer
See details and how to joinNCT04606446 - Phase 2Taking peopleNeoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- Where
- Baltimore, Boston, Buffalo, Chattanooga, Chicago, Cleveland, Edmonds, Fairfax, Gainesville, Houston, Little Rock, Los Angeles, Memphis, Nashville, New Haven, Oakland, Omaha, Pittsburgh, Saint Louis Park, Seattle, Stuart
- Age
- 18 years to 95 years
- People
- 630 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05061550 · EU 2023-508852-21-00 - No phaseTaking peopleUNC Pleural Fluid Registry
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 9,999
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT05620329 - No phaseTaking peopleDREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
- Where
- Chicago
- Age
- 18 years to 75 years
- People
- 125
- Run by
- Northwestern University
See details and how to joinNCT05671887 - Phase 1/2Taking peopleA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Where
- Atlanta, Austin, Canton, Celebration, Charleston, Cincinnati, Dallas, Dayton, Detroit, Fairfax, Greenville, Las Vegas, Los Angeles, Louisville, Margate, Nashville, New York, Orlando, Plantation, Saint Paul, Santa Monica, Spokane, Tamarac, Tucson
- Age
- 18 years and over
- People
- 862 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05914116 - Phase 1/2Taking peopleSafety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Where
- Boston, Chicago, Columbus, Fairfax, Houston, Irvine, Jacksonville, Los Angeles, New York, Rochester, Salt Lake City, San Francisco, Scottsdale, Washington D.C.
- Age
- 18 years and over
- People
- 191
- Run by
- Tango Therapeutics, Inc.
See details and how to joinNCT06810544 - Phase 1/2Taking peopleStudy of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
- Where
- Atlanta, Chicago, Cleveland, Glen Burnie, Houston, Omaha, Princeton, Tampa
- Age
- 18 years and over
- People
- 138
- Run by
- Molecular Partners AG
See details and how to joinNCT07278479 - Phase 1/2Taking peopleIntratumoral N17350 in Advanced Solid Tumors
- Where
- Buffalo, Houston, Los Angeles, San Diego, San Francisco
- Age
- 18 years and over
- People
- 275 worldwide
- Run by
- Onchilles Pharma Inc
See details and how to joinNCT07339176 - Phase 2Taking peopleT Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- Where
- Bethesda
- Age
- 18 years to 72 years
- People
- 85
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02133196 - Phase 1Taking peopleAOH1996 for the Treatment of Refractory Solid Tumors
- Where
- Duarte, Long Beach, Scottsdale
- Age
- 18 years and over
- People
- 92
- Run by
- City of Hope Medical Center
See details and how to joinNCT05227326 - Phase 1Taking peopleT Cell Receptor T Cells for Advanced KRAS G12V-mutant Non-small Cell Lung Cancer, Pancreas Cancer, Colon Cancer
- Where
- Seattle
- Age
- 18 years and over
- People
- 24
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT06043713 - Phase 2Not yet taking people in United StatesTemozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas
- Where
- Buffalo
- Age
- 18 years and over
- People
- 60
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT06202066 - Phase 1Taking peopleSafety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Where
- Atlanta, Denver, Los Angeles, Milwaukee, Newport, New York, Rochester, San Antonio
- Age
- 18 years and over
- People
- 100
- Run by
- Nammi Therapeutics Inc
See details and how to joinNCT06582017 - Phase 3Taking peopleStudy of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
- Where
- Abilene, Albuquerque, Anaheim, Anchorage, Dyer, Easton, Fort Wayne, Hinsdale, Hot Springs, Houston, Miami, Morehead, Muncie, New Braunfels, Sandusky, Springfield, Toledo, Tyler, West Salem
- Age
- 18 years and over
- People
- 695 worldwide
- Run by
- Gilead Sciences
See details and how to joinNCT06801834